⌘K

Login Start Free

Home/Filings/4/0001209191-20-024480

4//SEC Filing

Hoos Axel 4

Accession 0001209191-20-024480

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 4:25 PM ET

Size

5.3 KB

Accession

0001209191-20-024480

Insider Transaction Report

Form 4

Period: 2020-04-13

TCR2 THERAPEUTICS INC.TCRR

Director

Transactions

Award
Stock Option (Right to Buy)
2020-04-13+9,596→ 9,596 total
Exercise: $10.42Exp: 2030-04-12→ Common Stock (9,596 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on April 13, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1

filerCIK 0001809415

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 4:25 PM ET
Size: 5.3 KB

View on SEC.gov